Dr. Schneider is professor of psychiatry, neurology, and gerontology at the Keck School of Medicine and Leonard Davis School of Gerontology of the University of Southern California He directs the USC California Alzheimer’s Disease Center (State of California Department of Health Services), the clinical core of the USC Alzheimer’s Disease Research Center (National Institute on Aging), and the Geriatric Studies Center. He holds a master’s degree in biometry and epidemiology and has substantial expertise in clinical trials methods and drug development. His work involves treatment development with novel metabolic and neuroregenerative compounds, outcomes assessment, clinical trials methods, modelling, and simulations, and in silico screening of medications for slowing Alzheimer’s disease. In addition to participation on The Lancet Commission for dementia prevention, intervention, and care, he serves as an associate editor or editorial board member of several publications, including the Cochrane Dementia and Cognitive Improvement Group, Current Alzheimer Research, Alzheimer’s & Dementia, The Lancet Neurology, and Clinical Neuropharmacology among others; and is editor-in-chief emeritus of Alzheimer’s & Dementia: Translational Research and Clinical Interventions. He is a Fellow of the American College of Neuropsychopharmacology, and a Distinguished Life Fellow of the American Psychiatric Association.
